Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Senescence-associated reprogramming promotes cancer stemness
Maja Milanovic, Dorothy Ngo-Yin Fan, Dimitri Belenki, et al.
Nature (2017) Vol. 553, Iss. 7686, pp. 96-100
Closed Access | Times Cited: 903

Showing 1-25 of 903 citing articles:

Cellular Senescence: Defining a Path Forward
Vassilis G. Gorgoulis, Peter D. Adams, Andrea Alimonti, et al.
Cell (2019) Vol. 179, Iss. 4, pp. 813-827
Open Access | Times Cited: 2256
Hallmarks of Cellular Senescence
Alejandra Hernandez‐Segura, Jamil Nehme, Marco Demaria
Trends in Cell Biology (2018) Vol. 28, Iss. 6, pp. 436-453
Open Access | Times Cited: 2008
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Raffaella Di Micco, Valery Krizhanovsky, Darren J. Baker, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 22, Iss. 2, pp. 75-95
Open Access | Times Cited: 1487
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Ruchi Kumari, Parmjit Jat
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 1052
Cellular Senescence: Aging, Cancer, and Injury
Arianna Calcinotto, Jaskaren Kohli, Elena Zagato, et al.
Physiological Reviews (2019) Vol. 99, Iss. 2, pp. 1047-1078
Open Access | Times Cited: 961
Drug resistance and combating drug resistance in cancer
Xuan Wang, Haiyun Zhang, Xiaozhuo Chen
Cancer Drug Resistance (2019)
Open Access | Times Cited: 881
Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
Lia Walcher, Ann-Kathrin Kistenmacher, Huizhen Suo, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 764
Unmasking senescence: context-dependent effects of SASP in cancer
Douglas V. Faget, Qihao Ren, Sheila A. Stewart
Nature reviews. Cancer (2019) Vol. 19, Iss. 8, pp. 439-453
Closed Access | Times Cited: 657
Exploiting senescence for the treatment of cancer
Liqin Wang, Lina Lankhorst, René Bernards
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 340-355
Open Access | Times Cited: 521
The dynamic nature of senescence in cancer
Soyoung Lee, Clemens A. Schmitt
Nature Cell Biology (2018) Vol. 21, Iss. 1, pp. 94-101
Closed Access | Times Cited: 504
Senescence and cancer — role and therapeutic opportunities
Clemens A. Schmitt, Boshi Wang, Marco Demaria
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 10, pp. 619-636
Open Access | Times Cited: 451
Impaired immune surveillance accelerates accumulation of senescent cells and aging
Yossi Ovadya, Tomer Landsberger, Hanna Leins, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 444
Senescent Cells in Cancer Therapy: Friends or Foes?
Boshi Wang, Jaskaren Kohli, Marco Demaria
Trends in cancer (2020) Vol. 6, Iss. 10, pp. 838-857
Open Access | Times Cited: 391
Senescent cell clearance by the immune system: Emerging therapeutic opportunities
Larissa Prata, Inna G. Ovsyannikova, Tamar Tchkonia, et al.
Seminars in Immunology (2018) Vol. 40, pp. 101275-101275
Open Access | Times Cited: 385
Systems Biology of Cancer Metastasis
Yasir Suhail, Margo P. Cain, Kiran Vanaja, et al.
Cell Systems (2019) Vol. 9, Iss. 2, pp. 109-127
Open Access | Times Cited: 371
mTOR as a central regulator of lifespan and aging
David Papadopoli, Karine Boulay, Lawrence Kazak, et al.
F1000Research (2019) Vol. 8, pp. 998-998
Open Access | Times Cited: 357
Inducing and exploiting vulnerabilities for the treatment of liver cancer
Cun Wang, Serena Vegna, Haojie Jin, et al.
Nature (2019) Vol. 574, Iss. 7777, pp. 268-272
Open Access | Times Cited: 349
CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought
Mary E. Klein, Marta Kovatcheva, Lara E. Davis, et al.
Cancer Cell (2018) Vol. 34, Iss. 1, pp. 9-20
Open Access | Times Cited: 319
Cellular senescence: a key therapeutic target in aging and diseases
Lei Zhang, Louise E. Pitcher, Matthew J. Yousefzadeh, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 15
Open Access | Times Cited: 315
Targeting Cancer Cell Dormancy
Ariadna Recasens, Lenka Munoz
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 2, pp. 128-141
Closed Access | Times Cited: 293
Virus-induced senescence is a driver and therapeutic target in COVID-19
Soyoung Lee, Yong Yu, Jakob Trimpert, et al.
Nature (2021) Vol. 599, Iss. 7884, pp. 283-289
Open Access | Times Cited: 280
Meta-hallmarks of aging and cancer
Carlos López‐Otín, Federico Pietrocola, David Roiz‐Valle, et al.
Cell Metabolism (2023) Vol. 35, Iss. 1, pp. 12-35
Open Access | Times Cited: 274
Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence
Maria Grazia Vizioli, Tianhui Liu, Karl N. Miller, et al.
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 428-445
Open Access | Times Cited: 262
Targeting senescent cells in translational medicine
Marta Pàez‐Ribes, Estela González‐Gualda, Gary J. Doherty, et al.
EMBO Molecular Medicine (2019) Vol. 11, Iss. 12
Open Access | Times Cited: 261
Cellular senescence in development, regeneration and disease
Muriel Rhinn, Birgit Ritschka, William M. Keyes
Development (2019) Vol. 146, Iss. 20
Open Access | Times Cited: 246
Page 1 - Next Page

Scroll to top